Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Volume 27, Issue 18
  5. Article
Volume 27, Issue 18
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Pulmonary Arterial Hypertension (PAH) is a fatal disease with high morbidity and mortality. Cordycepin has anti-inflammatory, antioxidant and immune enhancing effects. However, the role of Cordycepin in the treatment of PAH and its mechanism is not clear.

Methods

The Cordycepin structure and PAH-related gene targets were obtained from public databases. The KEGG and GO enrichment analysis of common targets was performed in DAVID. PPI networks were also mapped using the STRING platform. AutoDock Vina, AutoDockTools, ChemBio3D and Pymol tools were selected for molecular docking of key targets. The therapeutic effects of Cordycepin on PAH were observed in Monocrotaline (MCT)-induced PAH rats and platelet-derived growth factor BB (PDGFBB)-induced rat pulmonary artery smooth muscle cells (PASMCs). The right ventricular systolic pressure (RVSP) was detected. HE staining, Western Blot, Scratch assay, EDU and TUNEL assays were used, respectively.

Results

Through Network Pharmacology and molecular docking, the Cordycepin-PAH core genes were found to be TP53, AKT1, CASP3, BAX and BCL2L1. In MCT-induced PAH rats, the administration of Cordycepin significantly reduced RVSP, and inhibited pulmonary vascular remodeling. In PDGFBB-induced PASMCs, Cordycepin reduced the migration and proliferation of PASMCs and promoted apoptosis. After the Cordycepin treatment, the protein expressions of TP53, Cleaved CASP3 and BAX were significantly increased, while the protein expressions of p-AKT1 and BCL2L1 were significantly decreased in MCT-PAH rats and PDGFBB-induced PASMCs.

Conclusion

This study identified that TP53, AKT1, CASP3, BAX, and BCL2L1 were the potential targets of Cordycepin against PAH by ameliorating pulmonary vascular remodeling, inhibiting the abnormal proliferation and migration of PASMCs and increasing apoptosis of PASMCs. which provided a new understanding of the pharmacological mechanisms of Cordycepin in the treatment of PAH.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073267432230925112002
2024-01-30
2025-01-13

  • From This Site

    /content/journals/cchts/10.2174/0113862073267432230925112002
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HassounP.M. Pulmonary arterial hypertension.N. Engl. J. Med.2021385252361237610.1056/NEJMra2000348 34910865
     [Google Scholar]
  2. BeikA. NajafipourH. JoukarS. RajabiS. IranpourM. KordestaniZ. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.Clin. Exp. Hypertens.202143327028010.1080/10641963.2020.1860080 33322932
     [Google Scholar]
  3. CoonsJ.C. PogueK. KolodziejA.R. HirschG.A. GeorgeM.P. Pulmonary arterial hypertension: A pharmacotherapeutic update.Curr. Cardiol. Rep.2019211114110.1007/s11886‑019‑1235‑4 31758342
     [Google Scholar]
  4. KylhammarD. KjellströmB. HjalmarssonC. JanssonK. NisellM. SöderbergS. WikströmG. RådegranG. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.Eur. Heart J.201839474175418110.1093/eurheartj/ehx257 28575277
     [Google Scholar]
  5. RafikovaO. Al GhoulehI. RafikovR. Focus on early events: Pathogenesis of pulmonary arterial hypertension development.Antioxid. Redox Signal.2019311393395310.1089/ars.2018.7673 31169021
     [Google Scholar]
  6. MandrasS.A. MehtaH.S. VaidyaA. Pulmonary hypertension: A brief guide for clinicians.Mayo Clin. Proc.20209591978198810.1016/j.mayocp.2020.04.039 32861339
     [Google Scholar]
  7. AnY. LiY. WangX. ChenZ. XuH. WuL. LiS. WangC. LuanW. WangX. LiuM. TangX. YuL. Cordycepin reduces weight through regulating gut microbiota in high-fat diet-induced obese rats.Lipids Health Dis.201817127610.1186/s12944‑018‑0910‑6 30522511
     [Google Scholar]
  8. ChenY.Y. ChenC.H. LinW.C. TungC.W. ChenY.C. YangS.H. HuangB.M. ChenR.J. The role of autophagy in anti-cancer and health promoting effects of cordycepin.Molecules20212616495410.3390/molecules26164954 34443541
     [Google Scholar]
  9. YangS.W. LimL. JuS. ChoiD.H. SongH. Effects of matrix metalloproteinase 13 on vascular smooth muscle cells migration via Akt–ERK dependent pathway.Tissue Cell201547111512110.1016/j.tice.2014.12.004 25595313
     [Google Scholar]
  10. ZhengQ. SunJ. LiW. LiS. ZhangK. Cordycepin induces apoptosis in human tongue cancer cells in vitro and has antitumor effects in vivo.Arch. Oral Biol.202011810484610.1016/j.archoralbio.2020.104846 32730909
     [Google Scholar]
  11. GeB. GuoC. LiangY. LiuM. WuK. Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C.Biofactors201945691291910.1002/biof.1558 31469455
     [Google Scholar]
  12. LiX. WeiS. NiuS. MaX. LiH. JingM. ZhaoY. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.Comput. Biol. Med.202214410538910.1016/j.compbiomed.2022.105389 35303581
     [Google Scholar]
  13. XiaoY. ChenP.P. ZhouR.L. ZhangY. TianZ. ZhangS.Y. Pathological mechanisms and potential therapeutic targets of pulmonary arterial hypertension: A review.Aging Dis.20201161623163910.14336/AD.2020.0111 33269111
     [Google Scholar]
  14. AldredM.A. MorrellN.W. GuignabertC. New mutations and pathogenesis of pulmonary hypertension: Progress and puzzles in disease pathogenesis.Circ. Res.202213091365138110.1161/CIRCRESAHA.122.320084 35482831
     [Google Scholar]
  15. XuJ.C. ZhouX.P. WangX.A. XuM.D. ChenT. ChenT.Y. ZhouP.H. ZhangY.Q. Cordycepin induces apoptosis and G2/M phase arrest through the ERK pathways in esophageal cancer cells.J. Cancer201910112415242410.7150/jca.32071 31258746
     [Google Scholar]
  16. LiuT. ZhuG. YanW. LvY. WangX. JinG. CuiM. LinZ. RenX. Cordycepin inhibits cancer cell proliferation and angiogenesis through a DEK interaction via ERK signaling in cholangiocarcinoma.J. Pharmacol. Exp. Ther.2020373227928910.1124/jpet.119.263202 32102917
     [Google Scholar]
  17. KongW. LiuW. WangM. HuiW. FengY. LuJ. MiranbiekeB. LiuH. GaoF. Cordycepin exhibits anti-bacterial and anti-inflammatory effects against gastritis in Helicobacter pylori-infected mice.Pathog. Dis.2022801ftac00510.1093/femspd/ftac005 35191475
     [Google Scholar]
  18. HennigsJ.K. CaoA. LiC.G. ShiM. MienertJ. MiyagawaK. KörbelinJ. MarcianoD.P. ChenP.I. RoughleyM. ElliottM.V. HarperR.L. BillM.A. ChappellJ. MoonenJ.R. DieboldI. WangL. SnyderM.P. RabinovitchM. PPARγ-p53-mediated vasculoregenerative program to reverse pulmonary hypertension.Circ. Res.2021128340141810.1161/CIRCRESAHA.119.316339 33322916
     [Google Scholar]
  19. YamanakaR. HoshinoA. FukaiK. UrataR. MinamiY. HondaS. FushimuraY. HatoD. Iwai-KanaiE. MatobaS. TIGAR reduces smooth muscle cell autophagy to prevent pulmonary hypertension.Am. J. Physiol. Heart Circ. Physiol.20203195H1087H109610.1152/ajpheart.00314.2020 32946259
     [Google Scholar]
  20. WuP. XieX. ChenM. SunJ. CaiL. WeiJ. YangL. HuangX. WangL. Elucidation of the mechanisms and molecular targets of qishen yiqi formula for the treatment of pulmonary arterial hypertension using a bioinformatics/network topology-based strategy.Comb. Chem. High Throughput Screen.202124570171510.2174/1386207323666201019145354 33076804
     [Google Scholar]
  21. da SilvaS.L.P. ThoméC.A.M. da Silva NetoT.L.A. MencalhaA.L. de Souza da FonsecaA. de PaoliF. Photobiomodulation prevents DNA fragmentation of alveolar epithelial cells and alters the mRNA levels of caspase 3 and Bcl-2 genes in acute lung injury.Photochem. Photobiol. Sci.201817797598310.1039/c8pp00109j 29922788
     [Google Scholar]
  22. ShiR. WeiZ. ZhuD. FuN. WangC. YinS. LiangY. XingJ. WangX. WangY. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.Pulm. Pharmacol. Ther.20184812413510.1016/j.pupt.2017.11.003 29133079
     [Google Scholar]
  23. YangY. YinL. ZhuM. SongS. SunC. HanX. XuY. ZhaoY. QiY. XuL. PengJ.Y. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.Biomed. Pharmacother.202113311105610.1016/j.biopha.2020.111056 33378960
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073267432230925112002
Loading
Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Cordycepin against Pulmonary Arterial Hypertension in Rats
Comb Chem High Throughput Screen 27, 2776 (2024); https://doi.org/10.2174/0113862073267432230925112002
/content/journals/cchts/10.2174/0113862073267432230925112002
/content/journals/cchts/10.2174/0113862073267432230925112002
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Cordycepin; DGEs; KEGG and GO enrichment analysis; molecular docking; network pharmacology; PAH

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test